Nano-X Imaging (NNOX) Net Income towards Common Stockholders (2019 - 2026)
Nano-X Imaging's (NNOX) quarterly Net Income towards Common Stockholders came in at -$14.1 million in Q1 2026, down 5.23% YoY from -$14.9 million in Q1 2025, and up 61.61% on a QoQ basis from -$36.8 million in Q4 2025.
Nano-X Imaging (NNOX) Net Income towards Common Stockholders (2019 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has 8 years of Net Income towards Common Stockholders data on file, last reported at -$14.1 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 5.23% year-over-year to -$14.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$79.3 million (down 43.63% YoY) and the FY2025 annual result came in at -$27.3 million, down 86.71% from the prior year.
- Net Income towards Common Stockholders rose to -$14.1 million in Q1 2026, from -$36.8 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of -$10.4 million in Q4 2023 to a low of -$54.9 million in Q4 2022.
- A 5-year average of -$19.4 million and a median of -$14.2 million in 2024 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders surged 81.05% — and 2025, when it slumped 157.99%.
- Tracing NNOX's Net Income towards Common Stockholders over 5 years: stood at -$54.9 million in 2022, then surged by 81.05% to -$10.4 million in 2023, then slumped by 36.93% to -$14.2 million in 2024, then tumbled by 157.99% to -$36.8 million in 2025, then surged by 61.61% to -$14.1 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$14.1 million (Q1 2026), -$36.8 million (Q4 2025), and -$13.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Nano-X Imaging | 61,661.55 | -44.16 Mn | -2.59 Mn | -14.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.11 Mn |
| Dec 31, 2025 | -36.76 Mn |
| Sep 30, 2025 | -13.87 Mn |
| Jun 30, 2025 | -14.56 Mn |
| Mar 31, 2025 | -13.41 Mn |
| Dec 31, 2024 | -14.25 Mn |
| Sep 30, 2024 | -13.83 Mn |
| Jun 30, 2024 | -13.73 Mn |
| Mar 31, 2024 | -12.43 Mn |
| Dec 31, 2023 | -10.41 Mn |
| Sep 30, 2023 | -21.56 Mn |
| Jun 30, 2023 | -17.54 Mn |
| Mar 31, 2023 | -11.95 Mn |
| Dec 31, 2022 | -54.90 Mn |
| Sep 30, 2022 | -19.92 Mn |
| Jun 30, 2022 | -23.81 Mn |
| Mar 31, 2022 | -21.97 Mn |
| Dec 31, 2021 | -22.08 Mn |
| Sep 30, 2021 | -13.47 Mn |
| Jun 30, 2021 | -13.58 Mn |